This information is intended only  for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for Cresemba® (isavuconazole) Great Britain (GB) and Northern Ireland (NI)​​​​​​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion and 100mg Hard Capsules - PI for GB
  • Cresemba (isavuconazole) 100mg Hard Capsules - PI for GB

Northern Ireland

  • Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion and 100mg Hard Capsules - PI for NI

Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion and 100mg Hard Capsules - PI for GB

Cresemba (isavuconazole) 100mg Hard Capsules - PI for GB

Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion and 100mg Hard Capsules - PI for NI

PP-CRB-GBR-1281 October 2021